These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


143 related items for PubMed ID: 1323472

  • 1. Immune-complex alveolitis in the rat: evidence for platelet activating factor and leukotrienes as mediators of the vascular lesions.
    de Lima WT, Sirois P, Jancar S.
    Eur J Pharmacol; 1992 Mar 17; 213(1):63-70. PubMed ID: 1323472
    [Abstract] [Full Text] [Related]

  • 2. Modulation by lipid mediators of immune complex-induced lung inflammation in mice.
    Steil AA, Tavares de Lima W, Jancar S.
    Eur J Pharmacol; 1998 Nov 13; 361(1):93-9. PubMed ID: 9851546
    [Abstract] [Full Text] [Related]

  • 3. Involvement of eicosanoids and PAF in immune-complex alveolitis.
    Tavares-de-Lima W, Teixeira CF, Sirois P, Jancar S.
    Braz J Med Biol Res; 1989 Nov 13; 22(6):745-8. PubMed ID: 2620187
    [Abstract] [Full Text] [Related]

  • 4. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes.
    Nagase T, Ishii S, Katayama H, Fukuchi Y, Ouchi Y, Shimizu T.
    Am J Respir Crit Care Med; 1997 Nov 13; 156(5):1621-7. PubMed ID: 9372685
    [Abstract] [Full Text] [Related]

  • 5. Release of eicosanoids in rat peritoneal cavity during the Arthus reaction. Effect of the PAF-antagonist BN-52021 and indomethacin.
    Jancar S, Braquet P, Sirois P.
    Int J Immunopharmacol; 1989 Nov 13; 11(2):129-32. PubMed ID: 2539337
    [Abstract] [Full Text] [Related]

  • 6. Effects of the platelet activating factor antagonists BN 52021 and BN 50730 on antigen-induced bronchial hyperresponsiveness and eosinophil infiltration in lung from sensitized guinea-pigs.
    Lagente V, Boichot E, Carre C, Guinot P, Mencia-Huerta JM, Braquet P.
    Clin Exp Allergy; 1993 Dec 13; 23(12):1002-10. PubMed ID: 10779293
    [Abstract] [Full Text] [Related]

  • 7. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
    László F, Whittle BJ, Moncada S.
    Br J Pharmacol; 1994 Dec 13; 113(4):1131-6. PubMed ID: 7889265
    [Abstract] [Full Text] [Related]

  • 8. Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma.
    Landgraf RG, Nossi DF, Sirois P, Jancar S.
    Prostaglandins Leukot Essent Fatty Acids; 2007 Dec 13; 77(3-4):163-72. PubMed ID: 17923399
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart.
    Hu W, Kinnaird AA, Man RY.
    Br J Pharmacol; 1991 May 13; 103(1):1097-102. PubMed ID: 1652337
    [Abstract] [Full Text] [Related]

  • 10. Intrapulmonary tumor necrosis factor triggers local platelet-activating factor production in rat immune complex alveolitis.
    Warren JS, Barton PA, Mandel DM, Matrosic K.
    Lab Invest; 1990 Dec 13; 63(6):746-54. PubMed ID: 2255183
    [Abstract] [Full Text] [Related]

  • 11. A role for phospholipid-derived inflammatory mediators in intestinal anaphylaxis in the rat.
    MacNaughton WK, Catto-Smith AG, Gall DG.
    J Pharmacol Exp Ther; 1992 Feb 13; 260(2):773-9. PubMed ID: 1738123
    [Abstract] [Full Text] [Related]

  • 12. Role of eicosanoids in PAF-induced increases of the vascular permeability in rat airways.
    Sirois MG, Plante GE, Braquet P, Sirois P.
    Br J Pharmacol; 1990 Dec 13; 101(4):896-900. PubMed ID: 2085713
    [Abstract] [Full Text] [Related]

  • 13. Lipid mediators, tumor necrosis factor and nitric oxide and their interactions in immune-complex-induced lung injury.
    Tavares de Lima W, Steil AA, Russo M, Starobinas N, Teixeira CF, Jancar S.
    Eur J Pharmacol; 1998 Sep 25; 358(1):69-75. PubMed ID: 9809871
    [Abstract] [Full Text] [Related]

  • 14. Paf-induced release of spasmogens from guinea-pig lungs.
    Jancar S, Thériault P, Lauzière M, Braquet P, Sirois P.
    Br J Pharmacol; 1989 Jan 25; 96(1):153-62. PubMed ID: 2538179
    [Abstract] [Full Text] [Related]

  • 15. Release of eicosanoids in rat peritoneal cavity stimulated with platelet-activating factor (PAF). Effect of the PAF-antagonist BN-52021.
    Jancar S, Braquet P, Sirois P.
    Prostaglandins Leukot Essent Fatty Acids; 1989 Jul 25; 37(1):23-4. PubMed ID: 2548218
    [Abstract] [Full Text] [Related]

  • 16. Interactions of arachidonic acid metabolites and platelet activating factor and mechanism of action in hypersensitivity reactions.
    Jancar S, Braquet P, Sirois P.
    Braz J Med Biol Res; 1987 Jul 25; 20(5):487-94. PubMed ID: 2838117
    [Abstract] [Full Text] [Related]

  • 17. Lung oedema induced by Tityus serrulatus scorpion venom in the rat.
    De Matos IM, Rocha OA, Leite R, Freire-Maia L.
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1997 Oct 25; 118(2):143-8. PubMed ID: 9440240
    [Abstract] [Full Text] [Related]

  • 18. Role of leukotrienes and platelet activating factor in acute gastric mucosal lesions in rats.
    Konturek SJ, Brzozowski T, Drozdowicz D, Garlicki J, Beck G.
    Eur J Pharmacol; 1989 May 19; 164(2):285-92. PubMed ID: 2759176
    [Abstract] [Full Text] [Related]

  • 19. Association of endothelin with lung hemorrhage induced by immune complexes in rats.
    Teixeira CF, Jancar S, Lima WT, D'Orléans-Juste P, Sirois P.
    Inflammation; 2004 Oct 19; 28(5):253-61. PubMed ID: 16133998
    [Abstract] [Full Text] [Related]

  • 20. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.
    McColl SR, Krump E, Naccache PH, Poubelle PE, Braquet P, Braquet M, Borgeat P.
    J Immunol; 1991 Feb 15; 146(4):1204-11. PubMed ID: 1846895
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.